Clinical Trials Sponsored by RhoVac APS

Total 1170 results

University of Aarhus
Aarhus University Hospital; Biomet Denmark Aps; Project coordinator Orthopaedic...

Active, not recruiting

The Effect of Implant Coating (BoneMaster) on Migration and Clinical Outcome in Hip Arthroplasty With the Exceed Cup

Osteoarthritis

Denmark
Smerud Medical Research International AS
SantoSolve AS

Unknown

Study of the Efficacy, Safety and Tolerability of Topical 2PX (Strontium Chloride Hexahydrate) in Patients With Chronic, Moderate-to-severe Lower Limb Post-amputation Stump Pain

Stump Pain

Denmark, Germany, Norway, Russian Federation, United Kingdom
Smerud Medical Research International AS
SantoSolve AS

Unknown

A Study of the Efficacy and Safety of 2PX in Patients With Pain Due to Osteoarthritis of the Knee

Pain | Osteoarthritis

United Kingdom, Finland, Poland, Russian Federation
AlgiPharma AS
Smerud Medical Research International AS

Completed

Safety and Efficacy of Inhaled OligoG CF-5/20 for the Treatment Cystic Fibrosis

Cystic Fibrosis

United Kingdom
Amylyx Pharmaceuticals Inc.
ALS Association; ALS Finding a Cure; Northeast ALS Consortium; Neurological Clinical... and other collaborators

Completed

AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS) (CENTAUR)

Central Nervous System Diseases | Nervous System Diseases | Neuromuscular Diseases | Neurodegenerative Diseases | Motor Neuron Disease | Amyotrophic Lateral Sclerosis | Spinal Cord Diseases | TDP-43 Proteinopathies

United States
Bispebjerg Hospital
University of Southern Denmark; Sygekassernes Helsefond; AP Moeller Foundation; Gigtforeninge... and other collaborators

Enrolling by invitation

Effects of Blood-flow Restricted Exercise Compared to Standard Rehabilitation in Patients With Knee Osteoarthritis

Osteoarthritis, Knee

Denmark
Syneos Health
Asieris Pharmaceuticals (AUS) Pty Ltd.

Not yet recruiting

A Study of APL-1501 Extended Release Capsules Compared to APL-1202 Immediate Release Tablets in Healthy Volunteers

Healthy Volunteers
AHS Cancer Control Alberta
Cross Cancer Institute

Not yet recruiting

Trial of Combined Radiotherapy and Vertebroplasty for Patients With Painful Metastatic Spinal Lesions

Spinal Metastases

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Recruiting

Unilateral Neck Radiotherapy in Head and Neck Cancer

Head and Neck Neoplasms

Canada
Equillium
Biocon Limited; Equillium AUS Pty Ltd

Completed

A Study of Itolizumab (EQ001) to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity in Uncontrolled Asthma (EQUIP)

Asthma

New Zealand, Australia
FoU Center Spenshult
The Swedish Rheumatism Ass

Active, not recruiting

The Halland Osteoarthritis Cohort (HALLOA)

Osteoarthritis, Knee | Osteoarthritis Hand | Osteoarthritis Generalized

Sweden
University Hospital, Grenoble
University Grenoble Alps; Linksium

Completed

Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study (TISSUE-PoC)

Scleroderma, Systemic

France
AHS Cancer Control Alberta
University of Calgary

Terminated

Sublingual Methadone for the Management of Cancer-related Breakthrough Pain in Outpatients

Pain | Cancer

Canada
Virginia Commonwealth University
American Psychological Association (APA)

Completed

Mindfulness Practices for Healthcare Professional Trainees

Stress

United States
AHS Cancer Control Alberta
Alberta Cancer Foundation

Unknown

APBI: 27Gy in 5 Fractions for Early Breast Cancer (ACCEL)

Breast Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Unknown

A Pilot Study to Evaluate the Feasibility of Combining Submandibular Salivary Gland Tx & IMRT Tomo to Reduce Xerostomia

Head and Neck Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours (DCA)

Neoplasms

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence

Sarcoma | Kidney Neoplasms | Testicular Neoplasms | Multiple Myeloma | Ovarian Neoplasms

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer

Prostatic Neoplasms | Neoplasm Metastasis | Palliative Care

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea

Metastatic Colorectal Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer

Prostate Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

An Initial Feasibility Study to Integrate MRI Based Brachytherapy and CT/MR Fused INRT in Treatment of Advance Cervical Cancer (IMRT)

Locally Advanced Cervical Cancer | Integrated MRI Based RT as Standard of Care
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue Sarcoma

Sarcoma

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation

Prostate Cancer | Osteoporosis

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe

Healthy

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Hypofractionated Radiotherapy for Small Cell Lung Cancer

Small Cell Carcinoma | Lung Neoplasm

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation

Prostatic Neoplasm

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Evaluating Taste and Smell Function and Food and Taste Preferences of Head and Neck Cancer Patients During Radiation Therapy/Chemotherapy

Head and Neck Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin

Colorectal Cancer | Metastasis | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, Colorectal
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Cone Beam CT Scanning in Lung and Bladder Cancer.

Bladder Carcinoma | Small Cell Carcinoma | Lung Neoplasm

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer

Carcinoma, Small Cell

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide

Glioma | Glioblastoma

Canada
Abdi Ibrahim Ilac San. ve Tic A.S.

Completed

Metabolic Syndrome Prevalence Study

Metabolic Syndrome

Turkey
Beth Israel Deaconess Medical Center
ALS Association

Completed

Electrical Impedance Myography as an Outcome Measure in Amyotrophic Lateral Sclerosis Clinical Trials

Amyotrophic Lateral Sclerosis

United States
Alberta Health services

Unknown

Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study

Hematologic Malignancy

Canada
Alberta Health services

Completed

Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases

Bone Neoplasms

Canada
Alberta Health services

Completed

HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma

Low Grade Lymphoma

Canada
Alberta Health services

Completed

Frequency of Circulating Tumour Cells in Stage II and Stage III Colon Cancer Patients

Colon Cancer

Canada
Alberta Health services

Completed

ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159

Peripheral Stem Cell/Marrow Transplant

Canada
Alberta Health services

Completed

Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function

Nasopharyngeal Neoplasms

Canada
ANRS, Emerging Infectious Diseases
P95; I-REIVAC; EPICONCEPT; Institut de Recherche en Santé Publique, France

Recruiting

Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in Adults (RESPIVAC)

COVID-19 | Influenza | Severe Acute Respiratory Infection (SARI)

France
Cedars-Sinai Medical Center
Penguin Cold Caps

Recruiting

Scalp Cooling to Prevent Hair Loss in Patients Undergoing Stem Cell Transplantation for Multiple Myeloma

Multiple Myeloma

United States
AHS Cancer Control Alberta
University of Calgary

Recruiting

mHealth Physical Activity Intervention for Young Cancer Survivors (AYA-PACT)

Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Trial of Hypofractionated Radiation Therapy for Glioblastoma

Glioblastoma

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Active, not recruiting

Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014

Neuroendocrine Tumors, NET

Canada
PharmaEssentia
Medpace, Inc.; EPS International; Brightech International

Active, not recruiting

Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance (SURPASS ET)

Essential Thrombocythemia

United States, Canada, Korea, Republic of, China, Hong Kong, Singapore, Taiwan, Japan
AHS Cancer Control Alberta
Alberta Cancer Foundation

Unknown

A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.

Papillary Thyroid Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs

Pancreatic Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline

Non-small Cell Lung Cancer | Advanced Solid Malignancies

Canada
AHS Cancer Control Alberta
Transplant Genomics, Inc.

Unknown

RATIO: Rational Approach To Immuno-Oncology (RATIO)

Metastatic Melanoma

Canada

Clinical Trials Sponsored by RhoVac APS

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations